These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32214151)

  • 1. Renal carcinoma CD105-/CD44- cells display stem-like properties in vitro and form aggressive tumors in vivo.
    Fiedorowicz M; Khan MI; Strzemecki D; Orzeł J; Wełniak-Kamińska M; Sobiborowicz A; Wieteska M; Rogulski Z; Cheda L; Wargocka-Matuszewska W; Kilian K; Szczylik C; Czarnecka AM
    Sci Rep; 2020 Mar; 10(1):5379. PubMed ID: 32214151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
    Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
    PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells.
    Zhang XF; Weng DS; Pan K; Zhou ZQ; Pan QZ; Zhao JJ; Tang Y; Jiang SS; Chen CL; Li YQ; Zhang HX; Chang AE; Wicha MS; Zeng YX; Li Q; Xia JC
    Mol Carcinog; 2017 Nov; 56(11):2499-2511. PubMed ID: 28621442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CD44+CD24+ gastric cancer stem cells.
    Zhang C; Li C; He F; Cai Y; Yang H
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1679-86. PubMed ID: 21882047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.
    Wan S; Zhao E; Kryczek I; Vatan L; Sadovskaya A; Ludema G; Simeone DM; Zou W; Welling TH
    Gastroenterology; 2014 Dec; 147(6):1393-404. PubMed ID: 25181692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Abolhasani M; Shariftabrizi A; Rasti A; Asgari M
    Cancer Biomark; 2018; 21(4):821-837. PubMed ID: 29286924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cells.
    Hsieh CH; Hsiung SC; Yeh CT; Yen CF; Chou YW; Lei WY; Pang ST; Chuang CK; Liao SK
    Oncotarget; 2017 Feb; 8(9):15593-15609. PubMed ID: 28121626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional significance of CD105-positive cells in papillary renal cell carcinoma.
    Matak D; Brodaczewska KK; Szczylik C; Koch I; Myszczyszyn A; Lipiec M; Lewicki S; Szymanski L; Zdanowski R; Czarnecka AM
    BMC Cancer; 2017 Jan; 17(1):21. PubMed ID: 28056882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of gastric cancer stem cells using the cell surface marker CD44.
    Takaishi S; Okumura T; Tu S; Wang SS; Shibata W; Vigneshwaran R; Gordon SA; Shimada Y; Wang TC
    Stem Cells; 2009 May; 27(5):1006-20. PubMed ID: 19415765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma.
    Zanjani LS; Madjd Z; Abolhasani M; Rasti A; Fodstad O; Andersson Y; Asgari M
    Biomark Med; 2018 Jan; 12(1):45-61. PubMed ID: 29243496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma.
    Shi C; Tian R; Wang M; Wang X; Jiang J; Zhang Z; Li X; He Z; Gong W; Qin R
    Cancer Biol Ther; 2010 Dec; 10(11):1182-90. PubMed ID: 20948317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
    Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
    PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
    Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
    Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
    Hurt EM; Kawasaki BT; Klarmann GJ; Thomas SB; Farrar WL
    Br J Cancer; 2008 Feb; 98(4):756-65. PubMed ID: 18268494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44+/CD105+ human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure.
    Liu T; Huang Y; Guo L; Cheng W; Zou G
    Int J Med Sci; 2012; 9(7):592-602. PubMed ID: 23028242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma.
    Janisiewicz AM; Shin JH; Murillo-Sauca O; Kwok S; Le QT; Kong C; Kaplan MJ; Sunwoo JB
    Int Forum Allergy Rhinol; 2012 Nov; 2(6):465-70. PubMed ID: 22887934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a tumor-initiating stem cell population in human renal carcinomas.
    Bussolati B; Bruno S; Grange C; Ferrando U; Camussi G
    FASEB J; 2008 Oct; 22(10):3696-705. PubMed ID: 18614581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.